RU92795U1 - DEVICE FOR INFUSION AND TRANSFUSION THERAPY - Google Patents

Abstract

 1. Device for conducting infusion and transfusion therapy, including a dropper, consisting of a sealed bag with a treatment solution, a medical tube, a needle connecting the medical tube to a sealed bag, an injection needle, and an electrolyzer, which is a diaphragmless activator, characterized in that the electrolyzer is placed between a sealed bag with a therapeutic solution and an injection needle, with the middle part of the medical tube along its length placed inside the cell. ! 2. The device according to claim 1, characterized in that a hollow glass of dielectric material with holes along the entire length of the glass wall is placed in a container with an activating liquid, and the medical tube placed inside the cell is wound along a helical line around the hollow glass.

Description

The utility model relates to the field of medicine and relates to the implementation of infusion and transfusion procedures using activated therapeutic solutions. A useful model can be used with the introduction of large quantities of liquid - saline, blood, glucose, etc. with the addition of drugs.

Infusion-transfusion therapy is one of the most important components of intensive care for most critical conditions. To this end, for a fairly long period of time, a wide range of therapeutic solutions have been used in clinical practice.Infusion-transfusion therapy is carried out to restore the volume and composition of the extracellular and intracellular water space of the body using parenteral fluid administration, including restoration of the proper content of chemical elements ( calcium, potassium, chlorine, etc.) necessary for normal life, as well as for the removal of toxic substances and stimuli yatsiya or, conversely, lowering the body of work intensity. Indications for infusion therapy are a lack of fluid volume that occurs with the loss of water and electrolytes, plasma and blood; changes in osmolarity, deficiency or excess of individual components of the plasma volume. Infusion therapy is also used when it is impossible to use the enteric pathway for the absorption of water and nutrients.

The most important parameter of a liquid, from the point of view of modern medicine, is its “charge” - the redox potential (ORP), which should be negative, since human cells have a negative ORP (-70 mV). Diseases occur when negative cell potential (AFP) drops below normal. Activated in one way or another, water has a negative ORP, a microcluster structure, is easily absorbed by the body, and replenishes negative blood cells and energy lost during illness.

In order to stimulate general immunity, including to enhance the activity of blood cells, therapeutic solutions introduced into the body, including during infusion therapy, are activated, which allows the blood to be enriched with trace elements ions with a change in blood structure and properties, but without changing its chemical composition. The phenomenon of effective treatment of a wide variety of diseases using biologically active fluids is well-known and confirmed by practice (Shironosov V.G. Physical fundamentals of resonant activation of water, p.220-221, 1st International Symposium "Electrochemical Activation in Medicine, Agriculture, Industry", collection of reports - M .; VNIIMT AO NPO Ekran, 1997. - P.248 .. In particular, positive clinical experience has been gained when using contactless activated physiological saline (DF) for droppers using the Kiselev method using a laser (Kisely BI to an adaptive method of treatment (artificial biofield source in medicine), St. Petersburg;. "Complex", Issue 1 1997, 9)..

In oncology, against the background of radiation therapy, the blood of patients is activated by intravenous laser irradiation, when a marked decrease in necrobiotic processes is noted on the 5-7th day after the operation, there is no edema and leukocyte tissue infiltration, vascularization improves, and the number of newly formed vessels significantly increases. The nature of the anti-inflammatory effect of intravenous laser irradiation is confirmed by changes in peripheral blood. Leukocytosis, ESR decreases, the proportion of segmented neutrophils decreases. The number of lymphocytes significantly increases by the end of the first week of the postoperative period. The use of intravenous laser irradiation of blood increases the absolute number of lymphocytes in peripheral blood, activates T-lymphocytes and stimulates their rosette-forming activity. The use of this method against the background of radiation therapy for cancer patients has a beneficial effect on the immune status of patients.

A known method of preparing blood for transfusion by exposure to blood with electromagnetic radiation (application for US Pat. RF No. 2001127417, MKI A61M 1/36 "Method of exposure to electromagnetic radiation", publ. 200.06.27)

A known method of treating blood for subsequent transfusion with therapeutic purposes. The method consists in additional processing of red blood cells by additional irradiation of blood during transfusion in order to increase the efficiency of restoring the functional properties of blood (US Pat. RF No. 2133613, MKI A61K 35/14, A01N 1/02 "Method for pre-transfusion processing of preserved red blood cells", publ. 1999.07 .27). In order to confirm the positive effects of activation, the studied liquids were studied water, saline and venous blood of people. (Konovalova N.A., Menshikova S.G., Shironosov V.G. Registration of the phenomenon of non-contact activation of liquids. Department of Biophysics, Udmurt State University, Izhevsk, Collection of abstracts VNKSF-8, Yekaterinburg, 2002. - p.590 -592).

The prototype is a device for preparing blood for transfusion using non-contact blood activation in a non-diaphragm electrolyzer, for example, in an Espero electrolyzer. Hermetic thin-walled polyethylene containers were filled with blood with a volume of V = 50 ml and placed in the cell for 30 minutes. The cell with a coaxial anode and cathode was filled with tap water with a volume of V = 1.8 L, with the addition of sodium chloride in an amount of 9 g / L. After activation, blood parameters were measured. (Prilutsky V.I., Bakhir V.M. Electrochemically activated water: Anomalous properties, mechanism of biological action. - M .; VNIIIMT AO NPO Ekran. 1997). This device for contactless activation is intended for the prevention and treatment of various diseases in order to stimulate general immunity, including to enhance the activity of blood cells. Activation of therapeutic solutions allows the blood to be enriched with trace elements ions, leads to activation, with a change in its structure and properties, but without changing the chemical composition of the blood.

However, this device for preparing for transfusion or infusion of therapeutic solutions, including blood and blood substitutes, like all known devices is limited in that:

1. The preparation of therapeutic solutions, including blood and blood substitutes, is carried out using activation in special thin-walled plastic bags;

2. it is impossible to activate therapeutic solutions, including blood and blood substitutes directly in the process of infusion or transfusion therapy;

3. infusion or transfusion is time limited. After removing the containers with the treatment solutions from the activating liquid, the relaxation of the ORP values of the treatment solutions begins, which after 30-40 minutes is reduced to the initial values.

The objective of the utility model is to create a device that enables the activation of therapeutic solutions, including blood and blood substitutes, directly during the infusion or transfusion therapy with the necessary indicators of the values of negative recovery potential (ORP) of the treatment solutions and preservation of these values at the end of the infusion (transfusion).

The problem is solved in that in a device for conducting infusion and transfusion therapy, including a dropper, consisting of a sealed bag with a treatment solution, a medical tube, a needle connecting the medical tube to a sealed bag, an injection needle, an electrolyzer - a diaphragmless activator, placed between the sealed bag with a treatment solution and an injection needle, the middle part of the medical tube along its length is placed inside the cell.

A hollow glass of dielectric material with openings along the entire length of the glass wall is placed in a container with an activating liquid, and a medical tube placed inside the cell is wound along a helical line around the hollow glass.

In FIG. presents a General view of the device for infusion and transfusion therapy.

The device includes a dropper 1, consisting of a sealed bag (plastic bag) 2 with a treatment solution or blood, a medical tube 3, a needle 4, a tap 5, and an electrolyzer in the form of a diaphragmless activator 6 with anode 7 and cathode 8, anode chamber 9, placed in capacity 10 with activating liquid.

The hollow glass 11, covering the cathode 8, is installed in a container 10 with an activating liquid. A sealed bag 2 with a treatment solution or blood through a needle 4 is connected to a medical tube 3 of a dropper 1, through which a treatment solution or blood flows to the patient through an injection needle 12. A hollow glass 11 installed in a container 10 with an activating liquid is made of dielectric material, and in the walls of the glass 11 holes are made to fill the entire volume of the tank 10 with activating liquid. On the outer wall of the glass 11, helical grooves can be made over the entire height to accommodate the medical tube 3. The length of the tube 3 in its part located inside the cell is at least 1.5 m.

The device operates as follows. To prepare the activating liquid, the container 10 is filled with distilled water, baking soda is added at the rate of 1 tbsp. spoon per 1 liter of water. Diaphragmless activator 6 with electrodes 7 and 8, placed in the capacitance 10, is included in the network and the activation of the liquid in the reservoir 10 is started. Activation is carried out to the ORP value = ≤-800 mV. The faucet 5 is opened and the treatment solution or blood is passed through the medical tube 3 along its entire length, up to the injection needle 12. Infusion of the treatment solution or blood transfusion is started. In this case, the treatment solution or blood is administered to the patient at a speed of not more than 1 drop per second. The activation of the treatment solution or blood is carried out to an AFP value of not lower than an AFP = -800 mV. The device is equipped with a system for automatically controlling the ORP of an activating fluid during infusion or transfusion.

As confirmation of the possibility of activating treatment solutions and bringing and maintaining the ORP values given by us after activation (after exiting the dropper) and at the end of the infusion (transfusion), we can use the works carried out by Vitold Bakhir Institute of Electrochemical Systems and Technologies in recent years, based on that conclusion that the ORP of the internal environment of a healthy person is always less than zero and is in the range from -200 to -300 millivolts. As a result of numerous experimental and clinical studies, scientists of this institute found that “the intensity of redox reactions depends on the activity of electrons in aqueous solutions, which is characterized by redox potential (ORP). The higher this parameter, the more “acidic” the medium, the more it is capable of oxidizing molecules, including molecules of substances alien to the body. And vice versa: the lower the AFP, the higher its regenerative, antioxidant ability. As a result of the electrochemical effect on water at the cathode, its redox potential decreases, it acquires antioxidant properties. ” In experiments with sealed thin-walled plastic bags with distilled water, which were placed in cylindrical containers filled with catholyte, catholyte (pH = 13.5, ORP = -950 mV) was obtained using the Emerald-SI installation. Activation was carried out for 30 min in freshly prepared solutions. (V.G. Shironosov, E.V. Shironosov. 2nd Int. Symp. "ECA in medicine, agricultural, industry". M: October 28-29, 1999

Moreover, from the above work it is known that the relaxation rate is determined by the time during which the measured characteristic (pH, redox potential, electrical conductivity, surface tension, catalytic activity, dissolving power, etc.) changes e times compared to the initial (immediately after the end of the electrochemical and electrophysical effects) value.

The negative ORP values obtained by us are preserved during the infusion (transfusion) due to the fact that the relaxation time of the treatment solutions is minimized due to the fact that the transfusion or infusion of treatment solutions is carried out simultaneously by electroactivation.

The table attached to the description of the utility model provides comparative data of the prototype device and the claimed device with respect to preserving the preset ORP values of the treatment solutions both during infusion (transfusion) and at the end of the process of administering solutions, blood or blood substitutes to the patient.

Thus, using the proposed device, the infusion of therapeutic solutions or blood transfusion is carried out simultaneously with their activation with the condition of constant maintenance of the electric potential of the activating fluid at a given level. In this case, the rate of administration of solutions to the patient and the value of the AFP are maintained at the required level. Non-contact activation of blood and its components, which changes the structure and properties of blood without changing its chemical composition, opens up new prospects for the practical use of this effect in medicine - for the prevention and treatment of various diseases, for blood incubators.

Table No. p / .p Prototype Patent Device Preservation of preset values of ORP solutions during infusion (transfusion) Claimed device Preservation of preset values of ORP solutions during infusion (transfusion) one. The preliminary activation of solutions in plastic bags is carried out (before infusion, transfusion) The values of the ORP of the solutions decrease after 30-40 minutes. after extraction of bags with activated liquid relaxation occurs The activation of treatment solutions occurs during infusion (transfusion) ORP values of treatment solutions after activation: after exiting the dropper ORP = -250 mV; at the end of the infusion (transfusion) OVN = -230 mV Blood AFP values after AFP activation = -340 mV at the end of AFP transfusion = -320 mV

EXAMPLES

Example 1

A 5% glucose solution in a glass bottle was used as an infusion treatment solution. An activating liquid was preliminarily prepared, for which the container was filled with distilled water. Baking soda was added there at the rate of 1 tbsp. spoon per 1 liter of water. An activator with electrodes was placed in a container with an activating liquid and connected to the network. Activation was carried out up to the ORP value not lower than = ≤ - 800 mV. Next, a dropper connected through a needle to a sealed bag with a therapeutic solution was included in the activation process, for which they opened the faucet and filled the tube with the healing solution along its entire length up to the injection needle, let the air out of the tube, closed the tap for a short time and inserted the needle into the patient's vein . They opened the faucet and started infusion of the solution.

The solution was administered to the patient at a rate of not more than 1 drop per second.

Glucose solution:

initial indicator (before entering the dropper) - ORP = + 420 mV

indicator after activation (after exiting the dropper) - ORP = -250 mV

indicator at the end of infusion - OVN = -230 mV

Example 2

Transfusion of venous donated blood was carried out, placed in an airtight plastic bag. Activation was carried out as in example 1.

Blood:

initial indicator - ORP = -30 mV

indicator after activation - ORP = -340 mV

indicator at the end of transfusion - ORP = -320 mV

Claims (2)

1. Device for conducting infusion and transfusion therapy, including a dropper, consisting of a sealed bag with a treatment solution, a medical tube, a needle connecting the medical tube to a sealed bag, an injection needle, and an electrolyzer, which is a diaphragmless activator, characterized in that the electrolyzer is placed between a sealed bag with a therapeutic solution and an injection needle, with the middle part of the medical tube along its length placed inside the cell. 2. The device according to claim 1, characterized in that a hollow glass of dielectric material with openings along the entire length of the glass wall is placed in a container with an activating liquid, and the medical tube placed inside the cell is wound along a helical line around the hollow glass.